Company Overview and News

 
Sundance Energy Australia Limited Reports First Quarter 2018 Financial and Operational Results

2018-05-16 globenewswire
DENVER, May 16, 2018 (GLOBE NEWSWIRE) -- Sundance Energy Australia Limited (ASX:SEA) (NASDAQ:SNDE) (“Sundance” or the “Company”), a U.S. onshore oil and gas exploration and production company focused in the Eagle Ford in South Texas, reported its first quarter 2018 financial and operations results.

 
A seismic exchange of strategy

2018-05-16 nzherald.co.nz
Last year there was just one initial public offering on the New Zealand Stock Exchange's main board versus eight de-listings — despite the local sharemarket having otherwise enjoyed a record-breaking 12 months.

 
[email protected]: ASX poised to edge higher at the open

2018-05-13 theage.com.au
Wall Street edged higher on Friday and the ASX is set up to open the week in a similar vein.

 
[email protected]: ASX poised to edge higher at the open

2018-05-13 smh.com.au
Wall Street edged higher on Friday and the ASX is set up to open the week in a similar vein.

 
Wages growth anchored near all time lows despite booming jobs growth

2018-05-13 abc.net.au
The recent release of enterprise bargaining agreements (EBAs) from the final quarter of 2017 certainly showed promise.

 
Decade-high hopes for market

2018-05-11 ntnews.com.au
The latest government figures show Australia has just days of emergency stocks of fuel in reserve amid widespread turmoil in the region and the Middle East. Fairfax Media is reporting the country has only a 22-day supply of crude oil, 59 days of LPG, 20 days of petrol, 19 days of aviation fuel and 21 days of diesel. The International Energy Agency expects countries to keep a 90-day supply, but Australia has under 50 days.

 
Bourse on longest run up in two years despite weekly peaks and troughs

2018-05-11 perthnow.com.au
THE Australian share market has notched up its longest winning streak in two years as it eyes off a new decade high.

 
Markets Live: ASX close to 10 year highs

2018-05-11 theage.com.au
The S&P/ASX 200 index finished up 10.7 points at 6,118.7, a gain of 0.2 per cent, helped on by energy stocks as the index fell just shy of a decade long high.

 
Markets are surging but we can't claim much credit

2018-05-11 theage.com.au
Something curious started happening about three weeks ago. The Australian dollar suddenly began a steep slide and the Australian sharemarket a sharp upturn.

 
ASX edges towards 10-year high

2018-05-11 theage.com.au
The ASX gained on Thursday to within 5 points of the highest intra-day level in 10 years.

 
Markets Live: ASX close to 10 year highs

2018-05-11 smh.com.au
The S&P/ASX 200 index finished up 10.7 points at 6,118.7, a gain of 0.2 per cent, helped on by energy stocks as the index fell just shy of a decade long high.

 
Markets are surging but we can't claim much credit

2018-05-11 smh.com.au
Something curious started happening about three weeks ago. The Australian dollar suddenly began a steep slide and the Australian sharemarket a sharp upturn.

 
ASX edges towards 10-year high

2018-05-11 smh.com.au
The ASX gained on Thursday to within 5 points of the highest intra-day level in 10 years.

 
R Kelly’s music banned

2018-05-10 ntnews.com.au
The ASX 200 has finished firmer for the ninth time in the past 10 sessions today. The index was boosted by a rally in the energy sector following a surge in oil prices overnight to 3.5 year highs.

 
Buffett not worried about China

2018-05-06 ntnews.com.au
The ASX 200 has climbed 1.85% over the week, recording its best weekly performance in 14 months. The index did decline on Friday though, slipping 0.6%.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 00212E103